The Med+ Program is for those who want access to prescription weight-loss medications alongside clinical oversight
In the context of retatrutide and alcohol, harm reduction means drinking less, spacing drinks further apart, planning safe transportation, monitoring for adverse effects, and making informed decisions rather than simply being told dont drink. Triple Receptor Agonist A medication that activates three different receptors: GLP-1, GIP, and glucagon
Preclinical studies have demonstrated that 5-Amino-1MQ effectively reprograms metabolism in key energy-regulating tissues: it counteracts obesity and associated fat accumulation, reduces pathological liver fat, and enhances the regenerative potential of aged skeletal muscle 1-3
doi: 10.1016/j.neuint.2019.04.010 15
This is non-negotiable for reproducible research